Dimitrios Drivas | White & Case LLP International Law Firm, Global Law Practice

Dimitrios Drivas

Partner, New York

T + 1 212 819 8286 / + 1 212 819 8200

E ddrivas@whitecase.com

“Dimitrios Drivas takes the lead in the firm’s life sciences patent litigation. He has an excellent track record of wins for leading global pharmaceuticals companies and is well respected by market sources.”

Chambers USA 2014

Overview

Chair of the Firm's Global Intellectual Property Practice Group, Dimitrios' practice focuses on patent litigation and counselling, and technology transfer.

A registered US patent attorney, clients benefit from his representation in complex patent and technology-related disputes in the Patent Office, courts and before arbitration panels.

His extensive practice experience, which spans a period of 30 years, enables him to guide clients through often highly technical matters. Drawing on his previous background in biotechnology, he brings particular insight to IP issues in the life sciences sector.

In addition to his litigation practice, Dimitrios provides clients with advice on the acquisition and licensing of intellectual property rights, joint development agreements and strategic alliances.

Bars and Courts

  • New York State Bar
  • US Supreme Court
  • US District Court for the Southern and Eastern Districts of New York
  • US Court of Appeals for the Federal Circuit
  • US Patent and Trademark Office

Education

  • JD, Fordham University School of Law
  • BS, Biochemistry, City University of New York

Languages

  • English

Experience

Dimitrios has over 30 years of experience in intellectual property law and the resolution of complex commercial disputes. He has been lead trial counsel in patent litigations, patent antitrust litigations and arbitrations involving complex transactions and agreements. Some recent representative cases on which he was trial counsel are:
In re Lipitor Antitrust Litigation
Defending Pfizer in class action antitrust litigation: In re Lipitor Antitrust Litig., 46 F.Supp.3d 523 (D.N.J. 2014).
In re Effexor Antitrust Litigation
Defending Pfizer in class action antitrust litigation: In re Effexor XR Antitrust Litig., 2014 WL 4988410 (D.N.J. 2014).
Pfizer v. Teva et al.
Represented Pfizer as plaintiff in ANDA litigation against several generic manufacturers: Pfizer, Inc., et al. v. Teva Pharm. et al., 882 F.Supp.2d 643 (D. Del. 2012); aff'd, 109 USPQ 2d 1652 (Fed. Cir. 2014).
Interval Licensing v. Google
Defending Google in patent infringement litigation: Interval Licensing LLC v. AOL, Inc., 2012 WL 12247714 (W.D. Wash. 2012) aff'd in part, rev'd in part, 766 F.3d 1364 (Fed. Cir. 2014).
Apotex v. UCB
Defending UCB in patent infringement litigation: Apotex v. UCB, 970 F.Supp.2d 1297 (S.D. Fla. 2013); aff'd, 763 F.3d 1354 (Fed. Cir. 2014).
Pfizer v. Teva et al.
Represented Pfizer as plaintiff in ANDA litigation against several generic manufacturers: Pfizer v. Ivax, 2010 WL 339042 (D.N.J. 2010); 855 F.Supp.2d 286 (D.N.J. 2012).

Awards & Recognition

Best Lawyers 2015

Litigation – Intellectual Property and Litigation – Patent

Leading Lawyer (Band 2), Chambers Global 2015

Intellectual Property: Patent – United States

Leading Lawyer (Band 2), Chambers USA 2014

Intellectual Property: Patent – New York

Recommended Lawyer, The Legal 500 USA 2014

Patent Litigation - Life Sciences/Chemicals

MVP, Law360, 2014

Life Sciences

Local Litigation Star, Benchmark Litigation, 2013

New York – Intellectual Property

Litigation Star, Benchmark Litigation, 2013

United States - Intellectual Property

Gold (top) ranking, IAM Patent 1000, 2012

Litigation